Image

Feasibility of a Cognitive Stepped Care Program for Adults With Brain Metastases

Feasibility of a Cognitive Stepped Care Program for Adults With Brain Metastases

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Background: Cognitive symptoms are common and often severe in patients with brain metastases, significantly impacting their quality of life and ability to manage cancer care. Currently, there is no standard approach for routinely assessing and managing these symptoms in oncology clinics.

Objective: This study aims to evaluate the feasibility, acceptability, and preliminary efficacy of the Cognitive Stepped Care Program (CSCP) in a Brain Metastases Clinic.

Methods: This is a prospective, mixed-methods feasibility study involving patients with brain metastases, their caregivers, and clinic staff. Patients will undergo routine cognitive symptom screening using a standardized tool. Based on symptom severity, they will receive tiered interventions ranging from no support, to education materials, to computerized cognitive testing with individualized debrief, with group strategy training and/or neuropsychological consultation, as needed. Patients will complete questionnaires before and after the intervention regarding their symptoms and quality of life. Patients, caregivers and staff will provide their feedback about the intervention through questionnaires and interviews.

Outcomes: Primary outcomes include feasibility and acceptability of the CSCP. Secondary outcomes include preliminary changes in cognitive symptoms, self-efficacy, and quality of life.

Significance: This study will inform the potential integration of a structured cognitive support program into standard care for patients with brain metastases and may provide a model for similar interventions in other oncology settings.

Eligibility

Patients

Inclusion Criteria:

  • Diagnosed with a brain metastasis for any primary cancer
  • Receiving follow-up care in the Brain Metastases Clinic
  • Adult (≥ 18 years)
  • Able to speak, read, and write in English
  • Able to provide written informed consent

Exclusion Criteria:

  • History of significant developmental/learning disability or psychiatric disorder, acquired neurological disorder (e.g., traumatic brain injury)
  • Poor performance status (ECOG ≥ 3)
  • Life expectancy \< 3 months
    Caregivers

Inclusion Criteria:

  • Self-identified or identified by consenting patient as a primary caregiver for a person with brain metastases receiving follow-up in the Brain Metastases Clinic
  • Adult (≥ 18 years)
  • Able to speak, read, and write in English
  • Able to provide written informed consent

Exclusion Criteria:

• N/A

Staff

Inclusion Criteria:

  • Currently working as a clinician or administrative staff member in the Brain Metastases Clinic
  • Adult (≥ 18 years)
  • Able to speak, read, and write in English
  • Able to provide written informed consent

Exclusion Criteria:

• N/A

Study details
    Brain Metastases
    Brain Metastasis

NCT07355348

University Health Network, Toronto

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.